SEARCH · PubMed Health
Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
First-pass radionuclide angiography, for the evaluation of ventricular function during peak physiological stress, requires the use of a low-energy point source for correction of motion artifacts. A design for the construction of a refillable 125I point source is presented.
The accuracy of non-invasive radionuclide angiography in detecting portal vein occlusion was assessed in 61 patients--10 with portal vein occlusion confirmed by conventional portography, 25 with chronic liver disease and a patent portal vein (mild = 12, severe = 13), and 26 with normal liver function, who served as controls. The median percentage portal venous flow for the portal vein occlusion group was 8% (range 1-30) (consistent with negligible flow) compared with 78% (52-87) for control subjects (p < 0.005) and 68% (61-80) and 49% (23-59) respectively for patients with mild and severe liver disease (p < 0.001 and p < 0.005). At a portal venous inflow of < 20%, the procedure had a specificity of 100% and sensitivity of 90% in diagnosing portal vein occlusion. Non-invasive radionuclide angiography provides a safe and accurate screening method for evaluating portal vein patency or occlusion in the investigation of portal hypertension or before liver transplantation.
The results of rest and exercise ECG, 201Tl myocardial perfusion imaging and equilibrium radionuclide angiography were analyzed in 71 consecutive patients referred for diagnosis or evaluation of coronary artery disease (CAD). In 45 patients the diagnosis was established either by catheterization or typical history. In this group the overall sensitivity for rest/exercise ECG was 66%, for 201Tl scans 74%, for both combined 79% and for the ejection fraction response to exercise determined by radionuclide angiography 97%. If only the exercise response was considered, the corresponding sensitivity values were 58% (ECG), 50% (201Tl scans), 71% (ECG + 201Tl) and 97% (radionuclide angiography). The specificity for coronary artery disease was determined to be 71% for ECG, 86% for 201Tl scans and 42% for radionuclide angiography. All patients with false-positive results by radionuclide angiography had cardiomyopathies, thus this test has a high specificity for left ventricular dysfunction rather than for CAD alone. Criteria developed from the analysis of the test results in the 45 patients with definite diagnoses were then applied to the evaluation of 26 additional patients with atypical chest pain. A diagnosis could be made in all but 5 of them and radionuclide angiography was again the single most reliable test. Based on this study a new approach for the noninvasive evaluation of patients with suspected coronary artery disease is proposed.
The ability of supine exercise electrocardiography and exercise radionuclide angiography to predict time to subsequent cardiac events (cardiac death, nonfatal myocardial infarction or late coronary bypass grafting or angioplasty) were compared in 265 patients with normal resting electrocardiograms who were not taking digoxin. All patients had undergone coronary catheterization and were initially treated medically. Follow-up study was performed at a median of 51 months. Separate logistic regression models, which had been previously developed to predict 3-vessel or left main coronary artery disease (CAD), were compared using a Cox regression analysis to predict time to a subsequent cardiac event. The exercise electrocardiography model, consisting of the magnitude of ST depression, exercise heart rate and patient gender, was a powerful predictor (chi-square = 30.8, p less than 0.0001) of subsequent events. The exercise radionuclide angiography model, which included the exercise response of the pressure-volume ratio in addition to the exercise electrocardiography variables, had similar prognostic power (chi-square = 31.8, p less than 0.0001). In a separate analysis considering only cardiac death and nonfatal myocardial infarction, the exercise electrocardiography model remained a significant predictor of events (chi-square = 12.2, p less than 0.001). None of the radionuclide angiography variables added significantly to the prognostic power of the exercise electrocardiography model. Thus, in patients with a normal resting electrocardiogram who are not taking digoxin, the supine exercise electrocardiography model that predicts 3-vessel or left main CAD also predicts future cardiac events. Exercise radionuclide angiography does not provide any additional prognostic information in such patients.
OBJECTIVES: This study assessed the agreement of left ventricular ejection fraction determinations from two-dimensional echocardiography, radionuclide angiography and contrast cineangiography. BACKGROUND: Previously published reports suggest that two-dimensional echocardiography, radionuclide angiography and contrast cineangiography are equally acceptable methods of assessing left ventricular ejection fraction on the basis of high coefficients of correlation. However, correlation of methods does not necessarily imply agreement. METHODS: In a prospective analysis, 25 consecutive subjects all had two-dimensional echocardiography and radionuclide angiography performed within 10 days of each other in the cardiology department of metropolitan community hospital. A retrospective computer search (Medline) revealed seven studies, using the coefficient of correlation (r), comparing two-dimensional echocardiographic left ventricular ejection fraction (n = 268) with radionuclide angiographic (n = 174) or contrast cineangiographic (n = 119) left ventricular ejection fractions. RESULTS: The eight individual studies (n = 293) comparing two-dimensional echocardiography with either radionuclide angiography or contrast cineangiography exhibited coefficients of correlation ranging from 0.78 to 0.93. Agreement analysis using the method of Bland and Altman was performed by averaging the results obtained from the two techniques and determining how disparate any single ejection fraction was (with 95% confidence limits) from the mean value. Agreement ranged from 23% to 42% around the mean ejection fraction. The average lack of agreement between the two methods for all studies involved was 17%, with an average r value of 0.86. CONCLUSIONS: Left ventricular ejection fraction determinations by means of two-dimensional echocardiography, radionuclide angiography and contrast cineangiography exhibit high correlation and only moderate agreement. High correlation does not always imply high agreement. These results suggest that, when validated by agreement analysis, multiple studies may not be necessary in appropriate clinical situations, potentially reducing costs.
Radionuclide angiography (RNA) permits analysis of contractility and conduction abnormalities. We determined the parameters of normal ventricular synchronization, assessed the reproducibility of the technique, and compared first harmonic (1H) and third harmonic (3H) analysis. Forty-four normal subjects (28 men and 16 women) were studied. RNA was performed in left anterior oblique (LAO) and left lateral (LL) projections. The onset (To), mean time (Tm), total contraction time (Tt) for right ventricle (RV) and left ventricle (LV), interventricular time (T(RV-LV) = Tm(LV - Tm(RV)) in LAO, and the apex-to-base time (T(a-b)) in LL were measured on the histograms of the time-activity curve. Reproducibility (R) was tested by studying 26 consecutive patients with two successive RNAs. RV starts contracting 25 ms before LV (To(RV) = 29 +/- 37 ms; To(LV) = 54 +/- 39 ms; mean +/- SD) with a 37 ms longer total contraction time. T(RV-LV) is 3 +/- 16 ms. In LL projection, apex and base contract synchronously: T(a-b) = 2 +/- 16 ms. 3H analysis enlarges all duration parameters (To, Tm and Tt), but does not alter synchronization (deltaT(a-b) and deltaT(RV-LV) between 1H and 3H <1%, p = NS). Reproducibility of the duration (T(tLV) and T(tRv)) and synchronization parameters (T(a-b) and T(RV-LV)) is high (R < or = 2.2%). In conclusion, the simultaneous contraction of right and left ventricles and of apex and base can be quantified by RNA phase analysis with high reproducibility. These results, consistent with published electrophysiological data, provide the basis for further non-invasive investigations of ventricular resynchronization in patients with basal electrical or mechanical asynchrony.
Exercise radionuclide angiography was performed in 65 normal subjects (group I), in 31 patients with exercise-induced transient thallium defects after acute myocardial infarction (AMI) (group II), and in 16 patients without exercise-induced transient thallium defects, angina or electrocardiographic changes after AMI (group III). Absolute left ventricular (LV) volumes were measured using a correction for attenuation in each patient. Similar peak heart rate-blood pressure products were achieved in groups II and III. Although the mean LV ejection fraction (EF) response to exercise in group III (increase of 0.11 +/- 0.10 units) closely resembled that of normal persons (increase of 0.14 +/- 0.09 units) and was significantly different from that of group II (decrease of 0.04 +/- 0.12), there was considerable individual variation. An abnormal EF response to exercise, defined as failure of EF to increase by at least 0.05 units, was found in 6 subjects (9%) in group I, 26 patients (84%) in group II, and 2 patients (13%) in group III. End-systolic volume failed to decrease in 10 subjects (15%) in group I, 25 patients (81%) in group II and 7 patients (44%) in group III. New regional wall motion abnormalities were found in no subject in group I, in 16 patients (52%) in group II and in only 1 patient (6%) in group III. Thus, although group responses of EF or end-systolic volume appeared to correlate with the presence or absence of ischemia, some patients with exercise-induced transient thallium defects after AMI responded normally to exercise radionuclide angiography stress testing and some patients without other evidence of exercise-induced ischemia after AMI responded to exercise radionuclide angiography testing abnormally.(ABSTRACT TRUNCATED AT 250 WORDS)
Radionuclide angiography was performed by intravenous injection of 99mTc-pertechnetate and recorded by serial gamma camera scintiphotographs. Its usefulness as a prebiopsy or preoperative procedure is demonstrated by two case reports of angiofibroma of the nasopharynx and it was also found to be useful for radiation therapy follow-up assessment. Radionuclide angiography offers a convenient and safe method to assess the vascularity of a mass and by this technique the surgeon may be alerted to the possibility of severe postbiopsy hemorrhage and also the occasional dramatic complications of radiological carotid angiography can be avoided.
In order to compare the three non-invasive exercise tests Ecg, Thallium myocardial perfusion imaging and radionuclide angiography in the diagnosis of coronary artery disease, the results of these tests in a consecutive series of 30 patients and 14 controls were analyzed. In all 88 symptom-limited exercise tests a significantly higher double product (heart rate x systolic blood pressure, mm Hg/min) was reached on a treadmill test (for Ecg and Thallium scintigraphy) as compared to the supine bicycle ergometer exercise (for radionuclide angiography: 243.1 +/- 61.1 vs. 215.2 +/- 46.5 x 10(2) (p less than 0.01). Considering all 132 diagnostic tests the overall sensitivity for rest/exercise Ecg was 67%, for Thallium scans 77%, for both combined 83% and for the ejection fraction response to exercise determined by radionuclide angiography 97%. If only the exercise response was considered, the corresponding sensitivity values were 60% (Ecg), 47% (Thallium scans), 70% (both tests combined) and 97% (radionuclide angiography). The specificity for coronary artery disease was determined to be 79% for Ecg, 86% for Thallium scintigraphy, 64% for Ecg/Thallium scans and 71% for radionuclide angiography. The most common reason for a false-positive result in all tests was found to be the diagnosis of cardiomyopathy, whereas most false-negative results were seen in patients with single vessel right coronary artery disease. Based on these results, the clinical implications of the three non-invasive tests in the diagnosis of coronary artery disease are discussed.
This study evaluated the ability of exercise radionuclide angiography performed early after percutaneous transluminal coronary angioplasty (PTCA) to predict subsequent restenosis. Forty-eight patients with initially successful PTCA underwent early (less than or equal to 1 month) exercise radionuclide angiography and late (greater than 1 month, mean 8) coronary angiography. Findings on exercise radionuclide angiography were normal in 17 patients (35% of the entire group); none of these 17 patients had restenosis. Of the 31 patients with abnormal radionuclide angiographic findings, 13 had restenosis. When the exercise radionuclide angiogram was used to stratify patients according to risk of restenosis, the negative predictive value of a normal test was 100% (95% confidence limits = 81 to 100%) and the positive predictive value was 42%. By this method, 35% of the entire study population could be classified as low risk for restenosis after PTCA. Early exercise radionuclide angiography identifies subgroups of patients who are at low and high risk for early restenosis after PTCA.
Left ventricular (LV) ejection fraction (EF) is an important measure of systolic function, with radionuclide angiography being the accepted standard for its determination. Echocardiography is ideal for repeated measurements of EF, but most methods are either subject to error in the presence of regional wall abnormalities or require cumbersome off-line analysis. Acoustic quantification is a recently introduced method that allows for the continuous on-line display of LV cavity dimensions, but the on-line algorithm for the measurement of EF has not been validated against an independent standard in the clinical setting. This study attempted to validate acoustic quantification in the determination of EF by comparison with off-line echocardiographic analysis and radionuclide angiography in 54 patients referred for this latter procedure. Acoustic quantification correlated well with off-line analysis in both the apical 4-chamber (r = 0.89, n = 43) and 2-chamber (r = 0.86, n = 26) views. Similarly, it also correlated well with radionuclide angiography in the 4-chamber (r = 0.81, n = 44) and 2-chamber (r = 0.83, n = 26) views. The correlation between the 2 methods was further improved when only the last 30 patients were assessed (r = 0.91, n = 25 for 4-chamber views; r = 0.86, n = 16 for 2-chamber views). The correlation was worse in patients with regional asynergy (r = 0.69, n = 17 for 4-chamber views; r = 0.76, n = 10 for 2-chamber views). Moreover, acoustic quantification tended to underestimate EF when compared with radionuclide angiography.(ABSTRACT TRUNCATED AT 250 WORDS)
First-pass radionuclide angiography of the terminal aorta was performed in 3 normal horses and a 6-year-old Standardbred intact male with aortoiliac thromboembolism. Thromboembolism caused chronic bilateral hind limb lameness, more severe in the right hind limb, was detected by rectal examination, and confirmed using transrectal ultrasonography. Using 99mTc-HDP, first-pass radionuclide angiography was combined with hind limb and pelvis bone (delayed) scintigraphy and revealed marked reduction in blood flow through both external iliac arteries and absence of blood flow in the internal iliac arteries. Quantitative analysis showed a decreased activity in the right iliac vessels in the clinic patient consistent with reduced blood flow when compared to control horses. First-pass radionuclide angiography provided a method to obtain diagnostic images of the terminal aorta and branches and a method to diagnose aortoiliac thromboembolism in the horse.
AIMS: Left ventricular function is an important outcome measure in patients with coronary artery disease, in particular in patients after myocardial infarction. It is reliably assessed by radionuclide angiography, but echocardiographic wall motion scoring might be an attractive alternative. METHODS: Four days after reperfusion therapy for acute myocardial infarction both radionuclide angiography and echocardiography were performed in 90 patients. Segmental wall motion scoring (WMSI) and visual estimation of the left ventricular ejection fraction (LVEF) was done by 2 independent observers. Repeated analysis was performed 1 month after the first reading. In 41 patients the LVEF was assessed quantitatively by tracing of endocardial outlines of the left ventricle. RESULTS: Both correlation with radionuclide angiography (estimated LVEF: r = 0.71, WMSI: r = -0.68, Tracing: r = 0.59) and inter- and intra-observer variability (estimated LVEF: 19% and 15%, WMSI: 65% and 59%) were in favour of the LVEF estimation method. Correlation with radionuclide angiography measurements was related to the quality of the echocardiogram and to the extent of coronary artery disease. CONCLUSION: Simple echocardiographic estimation of left ventricular ejection fraction in patients after reperfusion therapy for acute myocardial infarction proved to be superior to quantitative assessment of ejection fraction and to segmental wall motion scoring in comparison with radionuclide angiography.
PURPOSE: To investigate the agreement between two noninvasive methods, magnetic resonance (MR) velocity mapping and first-pass radionuclide angiography, to quantify the pulmonary-to-systemic blood flow ratio (QP/QS) in adults, adolescents, and children with left-to-right cardiac shunts. MATERIALS AND METHODS: The accuracy and precision of MR velocity mapping were studied in 12 control subjects (six men, six women) and in a phantom. MR velocity mapping and radionuclide angiography were performed on the same day in 24 patients (16 adults, two adolescents, six children; five male patients, 19 female patients). RESULTS: The mean error in QP/QS at MR velocity mapping in phantom experiments was -1% +/- 1 (mean +/- SD). In control subjects, QP/QS at MR velocity mapping was 1.03 +/- 0.03, and the cardiac index was 3.1 L/min/m2 +/- 0.2 and 3.2 L/min/m2 +/- 0.3 for women and men, respectively. In patients, QP/QS at radionuclide angiography was 14% +/- 13, higher than at MR velocity mapping. Interobserver variability was four times higher for radionuclide angiography compared with MR velocity mapping, 0% + 16 versus 0% +/- 4 (n = 12). The difference between repeated MR flow measurements in the same vessel was -1% +/- 5 (n = 36). CONCLUSION: The data suggest that MR velocity mapping is accurate and precise for measurements of shunt size over the whole range of possible QP/QS values.
UNLABELLED: Radionuclide exercise testing provides prognostic information in patients with known or suspected coronary artery disease (CAD). The relative contribution of 3 noninvasive tests--the Duke treadmill score (DTS), first-pass radionuclide angiography with calculation of the ejection fraction (RNA-EF), and perfusion SPECT--has not been comparatively assessed in a high-risk population undergoing all 3 tests. METHODS: We identified 997 patients (75% male; median age, 60 y) who underwent exercise treadmill testing with RNA-EF and SPECT perfusion imaging as a single test. The relative prognostic power of each test was evaluated in both an unadjusted manner and after adjustment for differences in baseline characteristics using Cox proportional hazards models. RESULTS: During a median follow-up of 4.1 y, 175 patients experienced outcome events. Without adjustment for baseline patient characteristics, each of the modalities proved highly predictive of the composite endpoint of cardiovascular death or nonfatal myocardial infarction (MI) (DTS chi(2) = 18.9, P = 0.0001; RNA-EF chi(2) = 34, P = 0.0001; SPECT chi(2) = 11.5, P = 0.0007). In clinically risk-adjusted models, RNA-EF was the most powerful predictor of cardiovascular death compared with the DTS and SPECT (chi(2) = 40.5, 27.6, and 19.8, respectively). Conversely, exercise SPECT perfusion was a stronger predictor of nonfatal MI than the DTS or RNA-EF (chi(2) = 26.7, 15.7, and 16.7, respectively). CONCLUSION: The DTS, perfusion SPECT, and RNA-EF are each significant predictors of cardiovascular events in high-risk patients. The optimal risk stratification of patients for CAD may include all 3 modalities.
BACKGROUND: Three-dimensional echocardiography is a promising technique for calculation of left ventricular ejection fraction, because it allows its measurement without geometric assumptions. However, few data exist that study its reproducibility and accuracy in patients. METHODS AND RESULTS: Twenty-five patients underwent radionuclide angiography and three-dimensional echocardiography that used the rotational technique (2 degrees interval and ECG and respiratory gating). Left ventricular volume and ejection fraction were calculated by use of Simpson's rule at a slice thickness of 3 mm. Analyses were performed to define the largest slice thickness required for accurate calculation of left ventricular volume and ejection fraction. Three-dimensional echocardiography showed excellent correlation with radionuclide angiography for calculation of left ventricular ejection fraction (mean +/- SD, 38.9 +/- 19.8 and 38.5 +/- 18.0, respectively; r = .99); their mean difference was not significant (0.03 +/- 0.17; P = .3), and they had a close limit of agreement (-0.385, 0.315). Intraobserver variability for radionuclide angiography and three-dimensional echocardiography was 4.2% and 2.6%, respectively, whereas interobserver variability was 6.2% and 5.3%, respectively. There was no significant difference between left ventricular volume and ejection fraction calculated at a slice thickness of 3 mm and that calculated at different slice thicknesses up to 24 mm. However, the standard deviation of the mean difference showed a stepwise increase, particularly at thicknesses > 15 mm. At a slice thickness of 15 mm, the probability of three-dimensional echocardiography to detect > or = 6% difference in ejection fraction was 80%. CONCLUSIONS: Three-dimensional echocardiography has excellent correlation with radionuclide angiography for calculation of left ventricular ejection fraction in patients and has an observer variability similar to that of radionuclide angiography. We recommend the use of a 15-mm-thick slice for accurate and rapid measurement of left ventricular volume and ejection fraction.
This study was performed to define the signs of cardiac tamponade on radionuclide angiography. The first pass studies were performed on a large field gamma camera, using a bolus of technetium pertechnetate. Three hundred and seventy-two studies were analysed. Cardiac tamponade requiring surgical intervention was present at the time in 28 studies. The diagnostic signs of cardiac tamponade on radionuclide angiography were: (1) Right ventricular compression--sensitivity 82%, specificity 97%, predicitive value of a positive result 72%, predictive value of a negative result 99%, and (2) Right atrial compression--sensitivity 21%, specificity 99%, predictive value of a positive result 75%, predictive value of a negative result 94%. Cardiac tamponade can be accurately diagnosed on radionuclide angiography and thus indicate those pericardial effusions which require urgent drainage.
Radionuclide angiography has become an accepted diagnostic method that is relied upon for its rapid, accurate and quantitative capabilities to characterize LV function. This method will continue to be used extensively in the future for the evaluation of patients with CAD. In addition to its common use to measure LV function at rest, the application of radionuclide angiography to assess LV function during exercise has proven prognostic potential that can be used in the clinical decision-making process in patients with known or suspected CAD.